@prefix c0x: <http://data.loterre.fr/ark:/67375/C0X> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dc11: <http://purl.org/dc/elements/1.1/> .

c0x:-NFNPJMJ0-J
  skos:prefLabel "laboratoire pharmaceutique américain"@fr, "U.S. pharmaceutical laboratory"@en ;
  a skos:Concept ;
  skos:narrower c0x:-B53NW754-R .

c0x:-BGVB935B-4
  skos:prefLabel "NVX-CoV2373"@en, "NVX-CoV2373"@fr ;
  a skos:Concept ;
  skos:related c0x:-B53NW754-R .

c0x:-B53NW754-R
  skos:prefLabel "Novavax"@en, "Novavax"@fr ;
  skos:inScheme c0x: ;
  skos:definition "Novavax, Inc. est une société américaine de vaccins. (Wikipédia)"@fr, "Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. (Wikipédia)"@en ;
  dc:modified "2020-12-15"^^xsd:date ;
  dc11:creator "Patricia Fener" ;
  a skos:Concept ;
  skos:exactMatch <https://en.wikipedia.org/wiki/Novavax>, <https://fr.wikipedia.org/wiki/Novavax> ;
  dc:created "2020-12-10"^^xsd:date ;
  skos:broader c0x:-NFNPJMJ0-J ;
  skos:related c0x:-BGVB935B-4 .

c0x: a skos:ConceptScheme .